home.aspx
 
EVENTS

THE 2021 CLINICAL DISCLOSURE VIRTUAL
THE 2021 CLINICAL DISCLOSURE VIRTUAL
May 11-12, 2021
Sophisticated and fully interactive conference experience, leverage best practices, networking and on-demand sessions will be available in one place, at the touch of a button.

Discover how Clinical Data Disclosure, Transparency & Plain Language Summaries Virtual Platform will elev...

Pharma Manufacturing Automation 2021
PHARMA MANUFACTURING AUTOMATION 2021
May 18-19, 2021
As the use of the robotics in the pharmaceutical manufacturing industry increases rapidly, it’s important to consider the benefits of the latest technologies for manufacturers, researchers and scientists. The advantages include greater speed and accuracy, more flexibility and more reliability ...

Adents Prodigi

SHARESHARESHARE
Leverage the business potential of your serialization data: Adents Prodigi is the only software solution able to generate, exchange, manage, enrich, analyze and enhance your serialization data.
SHARESHARESHARE

RELATED NEWS


Studying how individual cells are affected by chemical compounds, viral infections, and other agents can have profound practical consequences for the development of new drugs and novel therapies for disease. Conventionally, antivirals are studied in terms of how they influence entire cellular cultures, which can lead to researchers missing important events that happen in only some cells. To observe individual cells, lab techs have to manually load individual cells into dozens of plate wells, whi...

READ MORE

GlaxoSmithKline will invest $139 million in its Rockville, Maryland manufacturing site, boosting production capacity for its lupus drug Benlysta (belimumab) in response to growing demand....

READ MORE

Gateway Analytical announced today that they will be exhibiting and presenting at the upcoming Respiratory Drug Delivery (RDD) conference in Phoenix....

READ MORE

Roche is eyeing a new use for its checkpoint inhibitor immunotherapy Tecentriq after it posted results showing it extended patients’ lives by an extra two months compared with chemotherapy in untreated small cell lung cancer. The IMpower 133 trial was testing Tecentriq plus chemotherapy, compared with chemotherapy alone in patients with untreated extensive-stage small-cell lung cancer.
Results from the phase 3 trial announced at the International Association for the Study of Lung Ca...


READ MORE

Besides getting a new name, troubled Valeant is also in desperate need of some regulatory success to rebuild its image. But it’s not going to get it from a key plaque psoriasis combo drug Doubrii—at least not soon. The FDA has just rejected Doubrii, one of the seven products that Valeant hoped would collectively generate $1 billion of annual sales over the next five years, Valeant’s Ortho Dermatologics division announced Monday. In a statement, Chairman and CEO Joseph Papa said...
FIERCEPHARMA
READ MORE

IBM Watson Health and Pfizer Inc announced a collaboration that will utilize IBM Watson for Drug Discovery to help accelerate Pfizer's research in immuno-oncology, an approach to cancer treatment that uses the body's immune system to help fight cancer....

READ MORE

EVENTS

THE 2021 CLINICAL DISCLOSURE VIRTUAL
THE 2021 CLINICAL DISCLOSURE VIRTUAL
May 11-12, 2021
Sophisticated and fully interactive conference experience, leverage best practices, networking and on-demand sessions will be available in one place, at the touch of a button.

Discover how Clinical Data Disclosure, Transparency & Plain Language Summaries Virtual Platform will elev...

Pharma Manufacturing Automation 2021
PHARMA MANUFACTURING AUTOMATION 2021
May 18-19, 2021
As the use of the robotics in the pharmaceutical manufacturing industry increases rapidly, it’s important to consider the benefits of the latest technologies for manufacturers, researchers and scientists. The advantages include greater speed and accuracy, more flexibility and more reliability ...